Race, pharmacogenomics, and marketing: Putting BiDil in context

American Journal of Bioethics

Volumn 6, Issue 5, 2006, Pages

  Kahn, Jonathan ^a  

^a HAMLINE UNIVERSITY   (United States)

Author keywords

Commerce; Drug marketing; Pharmacogenomics; Race; Statistics

Indexed keywords

HYDRALAZINE; ISOSORBIDE DINITRATE; ISOSORBIDE HYDRALAZINE COMBINATION; ISOSORBIDE-HYDRALAZINE COMBINATION;

ADVERTIZING; AFRICAN AMERICAN; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; DRUG APPROVAL; DRUG COMBINATION; DRUG INDUSTRY; ETHICS; FOOD AND DRUG ADMINISTRATION; GENETICS; HUMAN; PATENT; PHARMACOGENETICS; REVIEW; UNITED STATES;

ADVERTISING; AFRICAN AMERICANS; CLINICAL TRIALS; DRUG APPROVAL; DRUG COMBINATIONS; DRUG INDUSTRY; HEART FAILURE, CONGESTIVE; HUMANS; HYDRALAZINE; ISOSORBIDE DINITRATE; PATENTS; PHARMACOGENETICS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 33749004274     PISSN: 15265161     EISSN: 15360075     Source Type: Journal    
DOI: 10.1080/15265160600755789     Document Type: Review

References (19)

1. AHeFT.org. 2005a. Implications of A-HeFT for patient care. Available at http://www.aheft.org/ implications. asp. (Accessed on March 22, 2005).
2. AHeFT.org. 2005b. A-HeFT and genomic medicine. Available at http://www.aheft.org/genomic.asp (Accessed on March 22, 2005).
3. Current Communications Company. 2005. Press release: New web site explains significance of the first major clinical trial to test effectiveness of heart failure medication in African Americans. March 22, 2005. Available at: http://biz.yahoo.com/prnews/ 050322/phtu027_3.html (Accessed on March 22, 2005).
4. Cutting Edge Information. 2004a. Cardiovascular marketing: Budgets, staffing and strategy. Available at http://www.researchandmarkets.com/ reportinfo.asp? report_id=53547&t=o&cat_id=16 (Accessed on February 15, 2005).
5. Cutting Edge Information. 2004b. Press release. April 13, 2004. Available at: http://www.biobn.com/ index.cfm?Page=viewnews&NewsID=0002150187 (Accessed on February 23, 2005).
6. Davies, K. 2005. Coming attractions. Bio-IT World, March 8, 2005. Available at http://www.bioitworld. com/archive/030805/firstbase.html (Accessed March 28, 2005).
7. Dries, D. L., D. V. Exner, B. J. Gersh, H. A. Cooper, P. E. Carson, and M. J. Domanski. 1999. Racial differences in the outcome of left ventricular dysfunction. New England Journal of Medicine 340: 609-616.
8. Editorial. 2005. Illuminating BiDil. Nature Biotechnology 23(4): 903.
9. Gillum R. F. 1987. Heart failure in the United States, 1970-1985. American Heart Journal 113: 1043-1045.
10. Herper, M. 2005. Race-based medicine arrives. Forbes. May 10, 2005. Available at online at: http://www. forbes.com/technology/2005/05/10/ cx_mh_0509racemedicine. html (Accessed May 19, 2005).
11. Holmes, T. 2004. Vigilante awarded BiDil ad campaign. December 27, 2004. Available at http://www. blackenterprise.com/ExclusivesEKOpen.asp?id=981. (Accessed January 26, 2005).
12. Kahn, J. 2003. Getting the numbers right: Statistical mischief and racial profiling in heart failure research. Perspectives in Biology and Medicine 46: 473-483.
13. Kahn, J. 2004. How a drug becomes "ethnic": Law, commerce, and the production of racial categories in medicine. Yale Journal on Health Policy, Law & Ethics 4: 1-46.
14. Loberg, M. 2005. NitroMed webcast at 23rd annual JP Morgan Healthcare conference, January 11, 2005. Available at: http://www.mapdigital.com/ jpmorgan/ healthcare05/ondemand.html#n Accessed January 25, 2005.
15. NitroMed. 2004. Press release. BiDil® named to American Heart Association's 2004 'Top 10 Advances' list. Available at: http://www.nitromed. com/01_11_05.asp (Accessed May 19, 2005).
16. Strategic Research Institute. 2005a. 6th Annual Multicultural Pharmaceutical Market Development and Outreach Conference. March 17-18, 2005. Available at: http://www.srinstitute.com/CustomerFiles/ upload/ brochure/CM453_brochure.pdf (Accessed March 30, 2005).
17. Strategic Research Institute. 2005b. 6th Annual Multicultural Pharmaceutical Market Development and Outreach Conference. Registration. Available at: http://www.srinstitute.com/ApplicationFiles/web/Web-Frame.cfm? web_id=324 (Accessed Januaray 11, 2005).
18. Taylor, A. L., S. Ziesche, C. Yancy, P. Carson, R. D'Agostino Jr., K. Ferdinand, M. Taylor, K. Adams, M. Sabolinski, M. Worcel, J. N. Cohn, and the African-American Heart Failure Trial Investigators. 2004. Combination of isosorbide dinitrate and hydralazine in blacks with heart failure. New England Journal of Medicine 351: 2049-2057.
19. Yancy, C. 2002. The role of race in heartfailure therapy. Current Cardiology Report 4: 218-225.